Will insurance cover your GLP-1 medication?

• Insurance coverage for GLP-1 medications is more likely for type 2 diabetes than for weight loss.
• Coverage for weight loss depends on your specific insurance plan, as some employers exclude it.
• Medicare and most state Medicaid programs do not cover GLP-1s for weight loss alone, but may cover them for other approved conditions.

About 1 in 8 U.S. adults reports using GLP-1s to lose weight, manage diabetes or treat heart disease. But whether insurance covers them depends on which condition you’re treating and which plan you have. 

With so many people using GLP-1 medications for weight loss, one question remains: do you need to pay out of pocket, or does insurance cover GLP-1 medications? 

Does insurance cover GLP‑1 medications? 

Yes, but with a caveat. Insurance covers GLP-1 medications for conditions such as diabetes or heart disease far more reliably than for weight loss. Coverage for weight loss depends on the insurance provider, location and whether your doctor deems it a medical necessity.  

Insurance coverage for GLP‑1s by use case  

GLP‑1 coverage for type 2 diabetes  

Patients with type 2 diabetes have the best chance of getting a GLP-1 covered by insurance.  

“Ozempic and Mounjaro usually have a strong chance of approval when a patient has type 2 diabetes,” says Joseph Zucchi, a physician associate and clinical supervisor at Transition Medical Weight Loss, a medical weight loss center in Salem, New Hampshire.   

He adds that insurers typically require proof. “In many cases, that means documentation of diagnostic criteria such as an A1C of 6.5% or higher or a fasting glucose of 126 or higher.” 

GLP‑1 coverage for weight loss  

Coverage for weight loss is different. Zucchi says coverage generally falls into three buckets: plans that cover obesity medications outright, plans that exclude weight loss coverage but may cover GLP-1s under certain secondary FDA-approved indications, and plans that exclude them altogether.  

“That middle category is especially important,” says Zucchi. Wegovy, for example, is FDA-approved to reduce cardiovascular risk in certain patients and Zepbound is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity.  

Both conditions give way to coverage that weight loss alone cannot.  

Which insurance plans cover GLP‑1 medications?  

Coverage varies depending on your insurance plan. The three main types  — employer-sponsored or private insurance, Medicare, and Medicaid  — each handle GLP-1s differently. 

Employer‑sponsored and private insurance  

Employer-sponsored and private insurance plans differ widely. Some cover GLP-1s for weight loss outright. Others cover them only when a secondary FDA-approved condition is present, like cardiovascular disease or sleep apnea. Some exclude weight loss coverage altogether.  

Because anti-obesity medication is usually optional rather than standard, your benefits depend on what your employer chooses to include in your plan.   

Medicaid coverage  

All state Medicaid programs cover GLP-1s for type 2 diabetes, but weight loss coverage is optional and left to each state. As of January 2026, only 13 state Medicaid programs covered GLP-1s for obesity treatment. That’s down from 16 in October 2025. 

That could shift. The BALANCE Model, a voluntary program from the Centers for Medicare and Medicaid Services (CMS), is expected to launch in Medicaid as early as May 2026. But participation is optional for states and manufacturers, which means coverage is not guaranteed for any individual enrollee. 

Medicare coverage for GLP‑1 drugs  

The law has long barred Medicare from covering weight loss drugs, and GLP-1s are still excluded from standard Part D coverage. Medicare does cover GLP-1s for FDA-approved uses other than weight loss, including type 2 diabetes, reducing cardiovascular risk and obstructive sleep apnea.  

That may change. Starting July 2026, a short-term program called the Medicare GLP-1 Bridge, designed as a bridge to the broader BALANCE model, will cover Wegovy, Zepbound and Foundayo for eligible Part D enrollees at a $50 monthly copayment. To qualify, you’ll need a BMI of 35 or higher alone or 27 or higher with additional criteria.  

The BALANCE Model’s launch in January 2027 isn’t guaranteed. CMS must confirm that 80% of Medicare beneficiaries are enrolled in participating plans by April 30.  

Why GLP‑1 medications are often denied  

The reason for a GLP-1 denial usually comes down to what you’re using it for.  

For type 2 diabetes, denials are often fixable. Missing lab work, an incomplete prior authorization or a documentation error can often be corrected and then resubmitted.  

But weight loss denials are different. “Many plans have a plan exclusion for weight-loss medications,” Zucchi says. “In those cases, the issue is often not medical necessity but the fact that the employer or plan simply did not elect to cover the medication in the first place.” 

Prior authorization and coverage requirements  

Even when a GLP-1 is covered, most insurance plans require prior authorization, which consists of a set of clinical questions your doctor must answer to justify why you qualify.  

“That often includes answering plan-specific clinical questions and submitting supporting documentation such as chart notes, lab work or a letter of medical necessity,” Zucchi says.  

For weight loss, most plans require documentation of at least three to six months of lifestyle changes, such as changes in nutrition and exercise. A BMI of 30 or higher or 27 or higher with a weight-related condition is usually required. Criteria vary by plan and can change without notice.  

How much do GLP‑1 medications cost without insurance?  

GLP-1 out-of-pocket costs range from $199 to over $1,300 per month, depending on the medication and whether it’s an injection or a pill. Here’s a breakdown of current prices: 

• Wegovy (pill): $199 
• Wegovy (injectable): $349 
• Ozempic: $1,027.51 
• Mounjaro: $1,112.16 
• Zepbound: $1,086.37 
• Saxenda: $1,349.02 

What to do if your insurance doesn’t cover GLP‑1s  

“I often tell my patients to see insurance denial as a detour and not a dead end,” says Nneoma Oparaji, a telemedicine physician at MDLIVE, a 24/7 on-call physician platform. “My recommendation is to pause, ask why it was denied and explore alternative options such as insurance appeals, manufacturer programs and other medication alternatives.” 

If appeals don’t pan out, lower-cost options do exist: 

• Check the manufacturer’s website. Novo Nordisk offers self-pay pricing through its NovoCare pharmacy, with some doses starting at $149 per month.  
• Use GoodRx. The site searches pharmacies for coupons and can reduce GLP-1 out-of-pocket costs. 
• Ask about alternatives. A different GLP-1 may be covered in your plan.  

Frequently asked questions  

How to get a GLP-1 covered by insurance?  

Call your insurance provider to ask what documentation they require, then work with your doctor to submit a prior authorization with supporting records like lab work, chart notes and evidence of prior lifestyle changes.  

How much is GLP-1 out of pocket?  

GLP-1 out-of-pocket costs typically range from $199 per month for the Wegovy pill to over $1,300 for Saxenda.  

How do I get 3 months of Ozempic for $25?  

If your insurance covers Ozempic, Novo Nordisk’s savings card lets eligible commercially insured patients pay as little as $25 per month for a 3-month supply. Government beneficiaries, including those on Medicare and Medicaid, do not qualify.